Search Results - "Schade, Amy E"
-
1
Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC
Published in PLoS biology (27-04-2023)“…While screening and early detection have reduced mortality from prostate cancer, castration-resistant disease (CRPC) is still incurable. Here, we report that…”
Get full text
Journal Article -
2
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
Published in The Journal of clinical investigation (15-08-2023)“…Despite the success of KRAS G12C inhibitors in non-small cell lung cancer (NSCLC), more effective treatments are needed. One preclinical strategy has been to…”
Get full text
Journal Article -
3
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells
Published in eLife (08-01-2020)“…Alterations involving serine-threonine phosphatase PP2A subunits occur in a range of human cancers, and partial loss of PP2A function contributes to cell…”
Get full text
Journal Article -
4
RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation
Published in Nucleic acids research (02-12-2019)“…Abstract Cell cycle gene expression occurs in two waves. The G1/S genes encode factors required for DNA synthesis and the G2/M genes contribute to mitosis. The…”
Get full text
Journal Article -
5
Coordinating gene expression during the cell cycle
Published in Trends in biochemical sciences (Amsterdam. Regular ed.) (01-12-2022)“…Cell cycle-dependent gene transcription is tightly controlled by the retinoblastoma (RB):E2F and DREAM complexes, which repress all cell cycle genes during…”
Get full text
Journal Article -
6
MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity
Published in Cell reports (Cambridge) (02-03-2021)“…To identify genes whose loss confers resistance to CHK1 inhibitors, we perform genome-wide CRISPR-Cas9 screens in non-small-cell lung cancer (NSCLC) cell lines…”
Get full text
Journal Article -
7
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution
Published in Nature (London) (09-10-2024)“…Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and has the highest rate of recurrence . The predominant standard of care for…”
Get full text
Journal Article -
8
Cyclin D–CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB
Published in Oncogene (01-06-2019)“…The retinoblastoma protein (RB) restricts cell cycle gene expression and entry into the cell cycle. The RB-related protein p130 forms the DREAM (DP, RB-like,…”
Get full text
Journal Article -
9
Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC
Published in PLoS biology (01-04-2023)“…While screening and early detection have reduced mortality from prostate cancer, castration-resistant disease (CRPC) is still incurable. Here, we report that…”
Get full text
Journal Article -
10
Abstract 2538: p53 activation induces cell cycle arrest by promoting DREAM and RB repression of cell cycle genes
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract p53 activation results cell cycle arrest at the G1/S checkpoint and the repression of early (G1/S) and late (G2/M) cell cycle gene expression in a p21…”
Get full text
Journal Article